Nifty Healthcare Index News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Laurus Labs Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 4
Author: KRChoksey

Keep track of all breaking news and updates on Nifty Healthcare Index from all sources in a single place.

Load latest

Lupin Ltd.

30 Apr 2025

2057.10

-1.84%

Company Update

Lupin Ltd - 500257 - Updates On Transfer Of Company''s API R&D Division And Over-The-Counter Consumer …

BSE India

Update on transfer of Company''s API R&D Division and Over-the -Counter Consumer Healthcare Business on Slump sale basis.

pdf

Laurus Labs Ltd.

30 Apr 2025

620.55

2.77%

Strong execution with positive Custom Synthesis outlook

Accumulate: Laurus Labs Ltd.

KRChoksey

Laurus Labs’ revenue for Q4FY25 stood at INR 17,203 Mn., up 19.5% YoY (+21.6% QoQ), which was above our estimates led by strong growth in Custom Synthesis segment.
Adj. EBITDA came in at INR 4,206 Mn., up 74.2% YoY (+47.5% QoQ), led by margin improvement of 768bps YoY (+430 bps QoQ) to 24.4%.

Laurus Labs Ltd. has an average target of 633.50 from 4 brokers.

Syngene International Ltd.

29 Apr 2025

627.95

-0.96%

Company Update

Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the details of the meeting to be held with the Analyst/Institutional Investor.

pdf

Max Healthcare Institute Ltd.

29 Apr 2025

1089.80

-0.76%

Max Healthcare boosts growth with 3,000 crore expansion, continues to eye strategic acquisitions across India

Business Line

Even as the company looks at organic expansions, it does not have any immediate fund raise plans.

Max Healthcare Institute Ltd. is trading above its 200 day SMA of 1016.8

Biocon Ltd.

29 Apr 2025

318.90

-0.90%

Company Update

Biocon Ltd - 532523 - Redemption Of Commercial Papers

BSE India

Redemption of Commercial Papers

pdf

Max Healthcare Institute Ltd.

29 Apr 2025

1089.80

-0.76%

Max Healthcare looking to expand bed capacity by at least 30% in FY26

Business Standard

Company inaugurates 300-bed greenfield hospital in Delhi's Dwarka, aims to invest 6,500 cr by FY28

Number of FII/FPI investors increased from 1051 to 1093 in Mar 2025 qtr.

Max Healthcare Institute To Invest Rs 6,000 Crore To Add 3,700 Beds By 2028

NDTV Profit | 29 Apr 2025 2 more

Lupin Ltd.

29 Apr 2025

2057.10

-1.84%

Board Meeting

Lupin Ltd - 500257 - Board Meeting Intimation for Considering And Taking On Record Audited Standalone …

BSE India

Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025 and recommend dividend, if any.

pdf

Cipla Ltd.

29 Apr 2025

1525.60

-1.58%

Corp. Note

Cipla Ltd - 500087 - Format of the Initial Disclosure to be made by an entity …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyCipla Ltd 2CIN NO.L24239MH1935PLC002380 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AAA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rajendra Chopra Designation: Company Secretary and Compliance Officer EmailId: cosecretary@cipla.com Name of the Chief Financial Officer: Ashish Adukia Designation: Global Chief Financial Officer EmailId: cosecretary@cipla.com Date: 29/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf